Dupont Capital Management’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-12,024
| Closed | -$348K | – | 1347 |
|
|
2020
Q1 | $348K | Sell |
12,024
-4,431
| -27% | -$128K | 0.01% | 800 |
|
|
2019
Q4 | $853K | Hold |
16,455
| – | – | 0.02% | 625 |
|
|
2019
Q3 | $903K | Buy |
16,455
+5,481
| +50% | +$301K | 0.02% | 557 |
|
|
2019
Q2 | $446K | Hold |
10,974
| – | – | 0.01% | 838 |
|
|
2019
Q1 | $332K | Hold |
10,974
| – | – | 0.01% | 917 |
|
|
2018
Q4 | $369K | Buy |
+10,974
| New | +$369K | 0.01% | 831 |
|
|
2017
Q3 | – | Sell |
-20,764
| Closed | -$1.02M | – | 940 |
|
|
2017
Q2 | $1.02M | Sell |
20,764
-7,522
| -27% | -$371K | 0.02% | 524 |
|
|
2017
Q1 | $1.23M | Sell |
28,286
-643
| -2% | -$27.9K | 0.03% | 467 |
|
|
2016
Q4 | $1.42M | Buy |
28,929
+2,220
| +8% | +$109K | 0.03% | 405 |
|
|
2016
Q3 | $1.28M | Sell |
26,709
-16,308
| -38% | -$780K | 0.03% | 402 |
|
|
2016
Q2 | $2.31M | Hold |
43,017
| – | – | 0.05% | 276 |
|
|
2016
Q1 | $1.92M | Sell |
43,017
-6,748
| -14% | -$302K | 0.04% | 331 |
|
|
2015
Q4 | $1.9M | Hold |
49,765
| – | – | 0.05% | 351 |
|
|
2015
Q3 | $1.58M | Hold |
49,765
| – | – | 0.04% | 375 |
|
|
2015
Q2 | $1.64M | Hold |
49,765
| – | – | 0.04% | 371 |
|
|
2015
Q1 | $2.05M | Hold |
49,765
| – | – | 0.04% | 363 |
|
|
2014
Q4 | $2.03M | Sell |
49,765
-340
| -0.7% | -$13.8K | 0.04% | 341 |
|
|
2014
Q3 | $1.84M | Hold |
50,105
| – | – | 0.03% | 345 |
|
|
2014
Q2 | $2.32M | Sell |
50,105
-1,590
| -3% | -$73.7K | 0.04% | 342 |
|
|
2014
Q1 | $2.13M | Sell |
51,695
-11,818
| -19% | -$486K | 0.03% | 362 |
|
|
2013
Q4 | $2.42M | Sell |
63,513
-9,837
| -13% | -$375K | 0.04% | 304 |
|
|
2013
Q3 | $1.76M | Sell |
73,350
-18,165
| -20% | -$435K | 0.03% | 400 |
|
|
2013
Q2 | $1.56M | Buy |
+91,515
| New | +$1.56M | 0.03% | 419 |
|